Patents by Inventor ARTURO BRAVO NUEVO

ARTURO BRAVO NUEVO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES
    Publication number: 20230301967
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Application
    Filed: January 23, 2023
    Publication date: September 28, 2023
    Applicant: Lankenau Institute for Medical Research
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and compositions for the treatment of retinopathy and other ocular diseases
    Patent number: 11564907
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: January 31, 2023
    Assignee: Lankenau Institute for Medical Research
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and compositions for the treatment of retinopathy and other ocular diseases
    Patent number: 11564906
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: January 31, 2023
    Assignee: Lankenau Institute for Medical Research
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and compositions for the treatment of ocular diseases and disorders
    Patent number: 11447568
    Abstract: Compositions and methods for the treatment of an ocular disease or disorder are disclosed.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: September 20, 2022
    Assignee: Lankenau Institute for Medical Research
    Inventors: Arturo Bravo-Nuevo, George C. Prendergast
  • Methods and compositions for the treatment of retinopathy and other ocular diseases
    Patent number: 11376236
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: July 5, 2022
    Assignee: Lankenau Institute for Medical Research
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES
    Publication number: 20200147045
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Application
    Filed: January 10, 2020
    Publication date: May 14, 2020
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES
    Publication number: 20200147046
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Application
    Filed: January 10, 2020
    Publication date: May 14, 2020
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES
    Publication number: 20200093793
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed. In accordance with one aspect of the instant invention, methods for treating, inhibiting (e.g., reducing), and/or preventing an ocular disease in a subject are provided. The methods comprise the administration of at least one inhibitor of the induction or activity of tryptophan degradation and/or of the downstream pathways that respond to this process. In a particular embodiment, the methods comprise the administration of an inhibitor of IDO1.
    Type: Application
    Filed: November 27, 2019
    Publication date: March 26, 2020
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and compositions for the treatment of retinopathy and other ocular diseases
    Patent number: 10525035
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 7, 2020
    Assignee: LANKENAU INSTITUTE FOR MEDICAL RESEARCH
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and Compositions for the Treatment of Retinopathy and Other Ocular Diseases
    Publication number: 20170360751
    Abstract: Compositions and methods for the treatment of ocular diseases are disclosed.
    Type: Application
    Filed: December 18, 2015
    Publication date: December 21, 2017
    Inventors: Alexander J. Muller, Arturo Bravo-Nuevo, Arpita Mondal, Courtney Smith, Hollie E. Flick
  • Methods and Compositions for the Treatment of Ocular Diseases and Disorders
    Publication number: 20170190789
    Abstract: Compositions and methods for the treatment of an ocular disease or disorder are disclosed.
    Type: Application
    Filed: April 10, 2015
    Publication date: July 6, 2017
    Inventors: Arturo Bravo-Nuevo, George C. Prendergast
  • Methods for maintaining or improving health, well-being and/or a physiological function in a subject
    Patent number: 9446007
    Abstract: The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. The invention further relates to a method of improving a physiological function in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: September 20, 2016
    Assignees: Dynamis Therapeutics, Inc., Lankenau Institute for Medical Research
    Inventors: Annette Tobia, Arturo Bravo Nuevo, Lisa Laury-Kleintop
  • METHODS FOR MAINTAINING OR IMPROVING HEALTH, WELL-BEING AND/OR A PHYSIOLOGICAL FUNCTION IN A SUBJECT
    Publication number: 20150202166
    Abstract: The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. The invention further relates to a method of improving a physiological function in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof.
    Type: Application
    Filed: March 30, 2015
    Publication date: July 23, 2015
    Inventors: ANNETTE TOBIA, ARTURO BRAVO NUEVO, LISA LAURY-KLEINTOP